Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.45 |
| ▸ | AGXT | P21549 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | DHFR | P00374 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3985723 | 0.98 | MAOA (0.44) | MAOAMAOBIDO1AGXTOPRM1 | |
| SCHEMBL10942039 | 0.78 | TSHR (0.44) | IDO1AGXTOPRM1OPRD1OPRK1 | |
| SCHEMBL21638945 | 0.76 | TSHR (0.43) | IDO1AGXTOPRM1OPRD1OPRK1 | |
| SCHEMBL2237483 | 0.74 | TSHR (0.41) | IDO1AGXTOPRM1OPRD1OPRK1 | |
| SCHEMBL11587465 | 0.74 | TSHR (0.41) | IDO1AGXTOPRM1OPRD1OPRK1 | |
| SCHEMBL11540623 | 0.74 | TSHR (0.41) | IDO1AGXTOPRM1OPRD1OPRK1 | |
| SCHEMBL19745328 | 0.73 | SLC1A3 (0.45) | TSHR | |
| SCHEMBL5139043 | 0.72 | TSHR (0.43) | IDO1AGXTOPRM1OPRD1OPRK1 | |
| SCHEMBL31187955 | 0.72 | MAOA (0.45) | MAOAMAOBIDO1TSHR | |
| SCHEMBL3645094 | 0.72 | DHFR (0.38) | IDO1DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2259790-A1 | ABCA-1 ELEVATING COMPOUNDS AND THE USE THEREOF | Gilead Palo Alto, Inc. (US) | 2010-12-15 | — | — | EP | disclosed |
| EP-2146967-A2 | TETRAHYDROINDOLE AND TETRAHYDROINDAZOLE DERIVATIVES | Serenex, Inc. (US) | 2010-01-27 | — | — | EP | disclosed |
| WO-2009100326-A1 | ABCA-1 ELEVATING COMPOUNDS AND THE USE THEREOF | CV THERAPEUTICS, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
| WO-2008130879-A2 | TETRAHYDROINDOLE AND TETRAHYDROINDAZOLE DERIVATIVES | SERENEX, INC. (US) | 2008-10-30 | — | — | WO | disclosed |
| EP-1633348-B1 | 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | ELAN PHARM INC (US) | 2008-10-08 | — | — | EP | disclosed |
| EP-1789431-A1 | PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS | CV THERAPEUTICS, INC. (US) | 2007-05-30 | — | — | EP | disclosed |
| EP-1768991-A1 | PROCESS FOR THE PREPARATION OF A1-ADENOSINE RECEPTOR AGONISTS | CV THERAPEUTICS, INC. (US) | 2007-04-04 | — | — | EP | disclosed |
| WO-2006026651-A1 | PARTIAL AND FULL AGONISTS OF A1 ADENOSINE RECEPTORS | CV THERAPEUTICS, INC. (US) | 2006-03-09 | — | — | WO | disclosed |
| WO-2006017052-A1 | PROCESS FOR THE PREPARATION OF A1 ADENOSINE RECEPTOR AGONISTS | CV THERAPEUTICS, INC. (US) | 2006-02-16 | — | — | WO | disclosed |
| EP-1334087-A1 | CYCLOALKYLFLUOROSULFONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2003-08-13 | — | — | EP | disclosed |
| WO-2002032858-A1 | CYCLOALKYLFLUOROSULFONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2002-04-25 | — | — | WO | disclosed |